Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 6937 to 6941 of 6941 entries
Sorted by: Best Match Show Resources per page
Novel genetic characteristics in low-grade fetal adenocarcinoma of the lung.

Thoracic cancer

Zhang S, Yin H, Zhang J, Yang L, Yang G, Jia J, Jiao Y, Ying J, Wang Y.
PMID: 34464028
Thorac Cancer. 2021 Oct;12(20):2789-2795. doi: 10.1111/1759-7714.14126. Epub 2021 Aug 31.

BACKGROUND: Low-grade fetal adenocarcinoma of the lung (L-FLAC) is a rare subtype of lung adenocarcinoma with undetermined histological features and genetic abnormalities. In this study, we attempted to investigate the pathological characteristics and genomic profiles of L-FLAC.METHODS: Among 9839...

Cite
Zhang S, Yin H, Zhang J, et al. Novel genetic characteristics in low-grade fetal adenocarcinoma of the lung. Thorac Cancer. 2021;12(20):2789-2795doi: 10.1111/1759-7714.14126.
Zhang, S., Yin, H., Zhang, J., Yang, L., Yang, G., Jia, J., Jiao, Y., Ying, J., & Wang, Y. (2021). Novel genetic characteristics in low-grade fetal adenocarcinoma of the lung. Thoracic cancer, 12(20), 2789-2795. https://doi.org/10.1111/1759-7714.14126
Zhang, Shuyang, et al. "Novel genetic characteristics in low-grade fetal adenocarcinoma of the lung." Thoracic cancer vol. 12,20 (2021): 2789-2795. doi: https://doi.org/10.1111/1759-7714.14126
Zhang S, Yin H, Zhang J, Yang L, Yang G, Jia J, Jiao Y, Ying J, Wang Y. Novel genetic characteristics in low-grade fetal adenocarcinoma of the lung. Thorac Cancer. 2021 Oct;12(20):2789-2795. doi: 10.1111/1759-7714.14126. Epub 2021 Aug 31. PMID: 34464028; PMCID: PMC8520817.
Copy Download .nbib Format: NLM
Prevention of Mother-to-Child Transmission of Hepatitis B Virus in the Western Pacific Region.

Clinical liver disease

Shan S, Jia J.
PMID: 34484699
Clin Liver Dis (Hoboken). 2021 Aug 30;18(1):18-21. doi: 10.1002/cld.1096. eCollection 2021 Jul.

No abstract available.

Cite
Shan S, Jia J. Prevention of Mother-to-Child Transmission of Hepatitis B Virus in the Western Pacific Region. Clin Liver Dis (Hoboken). 2021;18(1):18-21doi: 10.1002/cld.1096.
Shan, S., & Jia, J. (2021). Prevention of Mother-to-Child Transmission of Hepatitis B Virus in the Western Pacific Region. Clinical liver disease, 18(1), 18-21. https://doi.org/10.1002/cld.1096
Shan, Shan, and Jia, Jidong. "Prevention of Mother-to-Child Transmission of Hepatitis B Virus in the Western Pacific Region." Clinical liver disease vol. 18,1 (2021): 18-21. doi: https://doi.org/10.1002/cld.1096
Shan S, Jia J. Prevention of Mother-to-Child Transmission of Hepatitis B Virus in the Western Pacific Region. Clin Liver Dis (Hoboken). 2021 Aug 30;18(1):18-21. doi: 10.1002/cld.1096. eCollection 2021 Jul. PMID: 34484699; PMCID: PMC8405051.
Copy Download .nbib Format: NLM
Facile synthesis of recyclable 3D gelatin aerogel decorated with MIL-88B(Fe) for activation peroxydisulfate degradation of norfloxacin.

Journal of hazardous materials

Jing Y, Jia M, Xu Z, Xiong W, Yang Z, Peng H, Cao J, Xiang Y, Zhang C.
PMID: 34736183
J Hazard Mater. 2022 Feb 15;424:127503. doi: 10.1016/j.jhazmat.2021.127503. Epub 2021 Oct 14.

The application of traditional powder catalysts is limited by particle agglomeration and difficult recovery. In this work, a three-dimensional porous aerogel catalyst for organic pollutants degradation in water by activating peroxydisulfate (PDS) was successfully synthesized, which was obtained via...

Cite
Jing Y, Jia M, Xu Z, et al. Facile synthesis of recyclable 3D gelatin aerogel decorated with MIL-88B(Fe) for activation peroxydisulfate degradation of norfloxacin. J Hazard Mater. 2021;424:127503doi: 10.1016/j.jhazmat.2021.127503.
Jing, Y., Jia, M., Xu, Z., Xiong, W., Yang, Z., Peng, H., Cao, J., Xiang, Y., & Zhang, C. (2022). Facile synthesis of recyclable 3D gelatin aerogel decorated with MIL-88B(Fe) for activation peroxydisulfate degradation of norfloxacin. Journal of hazardous materials, 424127503. https://doi.org/10.1016/j.jhazmat.2021.127503
Jing, Ying, et al. "Facile synthesis of recyclable 3D gelatin aerogel decorated with MIL-88B(Fe) for activation peroxydisulfate degradation of norfloxacin." Journal of hazardous materials vol. 424 (2022): 127503. doi: https://doi.org/10.1016/j.jhazmat.2021.127503
Jing Y, Jia M, Xu Z, Xiong W, Yang Z, Peng H, Cao J, Xiang Y, Zhang C. Facile synthesis of recyclable 3D gelatin aerogel decorated with MIL-88B(Fe) for activation peroxydisulfate degradation of norfloxacin. J Hazard Mater. 2022 Feb 15;424:127503. doi: 10.1016/j.jhazmat.2021.127503. Epub 2021 Oct 14. PMID: 34736183.
Copy Download .nbib Format: NLM
Patients With Short PFS to EGFR-TKIs Predicted Better Response to Subsequent Anti-PD-1/PD-L1 Based Immunotherapy in EGFR Common Mutation NSCLC.

Frontiers in oncology

Liu S, Wu F, Li X, Zhao C, Jia Y, Jia K, Han R, Qiao M, Li W, Yu J, Zhou F, Xiong A, Chen B, Fan J, Ren S, Zhou C.
PMID: 33777802
Front Oncol. 2021 Mar 11;11:639947. doi: 10.3389/fonc.2021.639947. eCollection 2021.

BACKGROUND: Despite disappointing outcomes from immuno-monotherapy, studies reported that NSCLC patients with EGFR mutation may possibly benefit from combined immunotherapy. Whether the response to prior EGFR-TKI has association with the outcomes of subsequent immunotherapy remains unclear.PATIENTS AND METHODS: Advanced...

Cite
Liu S, Wu F, Li X, et al. Patients With Short PFS to EGFR-TKIs Predicted Better Response to Subsequent Anti-PD-1/PD-L1 Based Immunotherapy in EGFR Common Mutation NSCLC. Front Oncol. 2021;11:639947doi: 10.3389/fonc.2021.639947.
Liu, S., Wu, F., Li, X., Zhao, C., Jia, Y., Jia, K., Han, R., Qiao, M., Li, W., Yu, J., Zhou, F., Xiong, A., Chen, B., Fan, J., Ren, S., & Zhou, C. (2021). Patients With Short PFS to EGFR-TKIs Predicted Better Response to Subsequent Anti-PD-1/PD-L1 Based Immunotherapy in EGFR Common Mutation NSCLC. Frontiers in oncology, 11639947. https://doi.org/10.3389/fonc.2021.639947
Liu, Sangtian, et al. "Patients With Short PFS to EGFR-TKIs Predicted Better Response to Subsequent Anti-PD-1/PD-L1 Based Immunotherapy in EGFR Common Mutation NSCLC." Frontiers in oncology vol. 11 (2021): 639947. doi: https://doi.org/10.3389/fonc.2021.639947
Liu S, Wu F, Li X, Zhao C, Jia Y, Jia K, Han R, Qiao M, Li W, Yu J, Zhou F, Xiong A, Chen B, Fan J, Ren S, Zhou C. Patients With Short PFS to EGFR-TKIs Predicted Better Response to Subsequent Anti-PD-1/PD-L1 Based Immunotherapy in EGFR Common Mutation NSCLC. Front Oncol. 2021 Mar 11;11:639947. doi: 10.3389/fonc.2021.639947. eCollection 2021. PMID: 33777802; PMCID: PMC7991800.
Copy Download .nbib Format: NLM
Dimeric hexylitaconic acids from the marine-derived fungus .

Natural product research

Han J, Yang N, Wei S, Jia J, Lin R, Li J, Bi H, Song F, Xu X.
PMID: 32666830
Nat Prod Res. 2022 Jan;36(2):578-585. doi: 10.1080/14786419.2020.1793152. Epub 2020 Jul 15.

In the course of our efforts to search new secondary metabolites from marine-derived fungi, one new hexylitaconic acid derivative, 3-(5-methoxycarbonylpentyl)-4-methylfuran-2,5-dione (

Cite
Han J, Yang N, Wei S, et al. Dimeric hexylitaconic acids from the marine-derived fungus . Nat Prod Res. 2020;36(2):578-585doi: 10.1080/14786419.2020.1793152.
Han, J., Yang, N., Wei, S., Jia, J., Lin, R., Li, J., Bi, H., Song, F., & Xu, X. (2022). Dimeric hexylitaconic acids from the marine-derived fungus . Natural product research, 36(2), 578-585. https://doi.org/10.1080/14786419.2020.1793152
Han, Jiahui, et al. "Dimeric hexylitaconic acids from the marine-derived fungus ." Natural product research vol. 36,2 (2022): 578-585. doi: https://doi.org/10.1080/14786419.2020.1793152
Han J, Yang N, Wei S, Jia J, Lin R, Li J, Bi H, Song F, Xu X. Dimeric hexylitaconic acids from the marine-derived fungus . Nat Prod Res. 2022 Jan;36(2):578-585. doi: 10.1080/14786419.2020.1793152. Epub 2020 Jul 15. PMID: 32666830.
Copy Download .nbib Format: NLM
Showing 6937 to 6941 of 6941 entries